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SUMMARY 
This study was undertaken to determine the antidiabetic and antioxidant effects of oral 
administration of ethanolic extract of Moringa oleiferaflower on stretozotocin-induced diabetic rats at 100, 
200, and 300 mg/kg b.w.  
Thirty (30) male experimental albino rats were grouped randomly into six groups: groups A, B, and 
F are the control, diabetic control and reference drug groups, while C-E received 100, 200, and 300mg/kg 
b.w of the extract, respectively. Blood samples and organs were collected to assay for blood glucose level 
and antioxidant enzymes.  
Levels of blood glucose, serum lipids and lipid peroxidation as well as aspartate aminotransferase 
(AST), alkaline phosphatase (ALP), and alanine aminotransferase (ALT) activities were significantly 
reduced (p<0.05) in STZ-induced diabetic rats orally administered ethanolic extract of M. oleifera flower. 
However, the body weight; catalase and superoxide dismutase activities were significantly increased (p < 
0.05) when compared with the controls.  
M. oleifera flower ethanolic extract administered orally therefore exhibited improved lipid 
metabolism, glucose-lowering potential and is hence beneficial in preventing diabetic complications as a 
result of lipid peroxidation and oxidative systems in streptozotocin-induced diabetic rats. It could thus be 
employed therapeutically in managing diabetes mellitus. 
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INTRODUCTION 
Diabetes mellitus, a complex multisystem and 
metabolic disorder is characterized by relative or 
absolute defects in insulin secretion and disturbances in 
carbohydrate, protein and lipid metabolism (1). The 
world population with diabetes is rising yearly and by 
the year 2030, it is expected to hit 439 million (2). 
Diabetes mellitus has been classified into two major 
types: type 1 is also referred to as insulin-dependent 
diabetes mellitus (IDDM) and type 2 is referred to as 
non-insulin-dependent diabetes mellitus (NIDDM). 
Type I diabetes, an autoimmune disease, normally 
presents with local inflammatory reactions in and 
around islets, which results in the selective destruction 
of β-cells that secrete insulin. Peripheral insulin 
resistance and impaired insulin secretion are seen in 
type 2 diabetes (3). 
Diabetes mellitus has been shown to be as-
sociated with oxidative stress, leading to an increased 
production of reactive oxygen species (ROS) such as 
hydroxyl radical (OH•), hydrogen peroxide (H2O2), 
and superoxide anion radical (O2•−) or diminished 
availability of endogenous antioxidants. In addition to 
oxygen free radical generation, non-enzymatic protein 
glycosylation, formation of peroxides and auto-
oxidation of glucose have contributed to the invol-
vement of oxidative stress in the pathogenesis of 
diabetes mellitus (4, 5). Lipid peroxidation (LPO), a key 
marker of oxidative stress induced by free radicals 
results in the oxidative worsening of poly-unsaturated 
fatty acids that consequently results in massive 
membrane damage and dysfunction (6). 
The various endogenous antioxidants in cells 
help to prevent or mend the damage caused by free 
radicals, and also serve to regulate signaling pathways 
that are redox-sensitive. Superoxide radicals are 
inactivated through conversion to hydrogen peroxide 
and molecular oxygen by the superoxide dismutase, 
and hydrogen peroxide is itself converted to water by 
catalase and peroxidases causing membrane desta-
bilization, damages to DNA and proteins, 
and oxidation of low-density lipoprotein (LDL); 
ROS are implicated in mutagenesis, cellular aging, 
carcino-genesis, and coronary heart disease (6) 
Moreover, increased LPO in diabetics can be due to 
an upsurge in oxidative stress in the cell due to a 
weakened anti-oxidant protective systems (7). 
Plants are known to be rich in natural anti-
oxidants such as carotenoids, tocopherols, flavonoids,  
vitamin C and several other phenolic compounds (8). 
Ethnobotanical information has it that plants num-
bering more than 800 are in use traditionally for 
treating diabetes owing to their potency, fewer side 
effects, and cheapness (9). Through their normo-
glycemic effect, ability to improve lipid metabolism, 
antioxidant defense system and capillary function, 
botanical products can enhance glucose metabolism 
and the overall condition of individuals with diabetes 
(10). 
Moringa oleifera, a tropical highly treasured 
plant, is found in several countries of the tropical and 
subtropical regions. It is a perennial softwood tree with 
low quality timber belonging to the single genus family 
Moringaceae. It is a small, rapidly developing or-
namental tree which is believed to be of Indian origin. 
Several parts of the tree including its root, pods, bark, 
and leaves are of importance in traditional medicine for 
treating human diseases, whereby the leaves are 
enriched in A and C vitamins. The therapeutic effects 
of M. oleifera include: antibiotic (11), anticancer (12), 
antiulcerogenic (13), analgesic (14), antiurolithiatic (15) 
and larvicidal (16). Parts of the plant including the 
roots, seed, leaves, bark, fruit, immature pods and 
flowers act as cardiac and circulatory stimulants, 
possess antitumor (17), antipyretic, anti-inflammatory, 
antiepileptic and antiulcer properties (18). It is also 
known to be antisplasmodic (19), diuretic (20), anti-
hypertensive (21), antihyperlipdaemic (22), hepato-
protective, antioxidant, antidiabetic, (23), antifungal 
and antibacterial (24). Highly appreciable levels of four 
natural antioxidants of dietary origin: vitamins A, C 
and E and phenolics are found in M. oleifera. Studies 
have estimated 46 antioxidants in Moringa which are 
important to cells in combating free radicals (25-27). 
This study was therefore aimed at investigating the 
effect of ethanolic extract of dried flowers of M. oleifera 
in streptozotocin-induced diabetes in rats. 
MATERIALS AND METHODS 
Chemicals used 
Streptozotocin (STZ) was a product of Sigma 
Chemical Company (USA). The assay kits for cho-
lesterol, LDL, HDL, triglyceride, ALT, AST were 
products of Randox Laboratory Ltd, Co-Atrim (UK). 
Glibenclamide was a product of TuyilPharmaceu-
ticals Limited, Nigeria. All other reagents used were 
of analytical grades. 
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Plant material 
The freshly harvested flower of M. oleifera was 
a gift from the University of Ilorin Moringa Plantation 
in Ilorin, Kwara State, Nigeria, and was identified at 
the Herbarium Unit, Plant Biology Department, 
University of Ilorin, Nigeria, where herbarium speci-
men was deposited with Voucher Specimen Number: 
U.I.H 002/1008. 
Phytochemical screening 
A preliminary phytochemical screening of the 
flowers of M. oleifera was conducted using a standard 
method of analysis as described by Sofowora (28). 
Extract preparation 
Fresh flowers of M. oleifera were air-dried at 
40oC using Uniscope SM9053 laboratory Oven, Surgi-
friend Medicals, England. The dried flowers (161 g) 
were then pulverized using an electric blender 
(Crown Star Blender CS-242B, Trident (H.K) Ltd, 
China) after which the resulting powder was ex-
tracted in 95% ethanol for 72 hours at 37oC with 
continuous shaking. This extract was then filtered 
using Whatman No 1 filter paper and the filtrate 
obtained was concentrated in a water bath at 40oC. 
The extract was stored in a refrigerator at -4oC. 
Calculated amounts were reconstituted in distilled 
water to give the required doses of 100, 200, and 300 
mg/kg body weights used for oral administration. 
Experimental animals 
Thirty male experimental albino rats (Rat-
tusnorvegicus) of weight 151±5.00 g obtained from the 
Animal Holding Unit of Biochemistry De-partment, 
University of Ilorin, Ilorin, Nigeria were acclimatized 
for 2 weeks before the experiment. The animals were 
housed in clean wooden cages, fed standard diets and 
were allowed unhindered access to water with 
regulated 12 h light/dark cycle. 
Induction of diabetes 
Diabetes was induced via intra-peritoneal injec-
tion of 45mg/kg body weight of freshly prepared 
streptozotocin (STZ). STZ was prepared in citrate 
buffer (0.1M, pH 4.5). Prior to diabetes induction, the  
animals were fasted overnight and the overnight 
fasted-rats were confirmed diabetic by measuring 
blood glucose concentration 96 h after injection with 
STZ using Accu-Chek glucometer. Rats belonging to 
the non-diabetic control group were injected with just 
citrate buffer. Blood sample was obtained from tail 
puncture of the rats for the fasting blood glucose 
determination, and animals with blood glucose values 
greater than 200 mg/dL were considered diabetic; 
blood glucose level was checked every day for 7 days. 
Treatment was commenced on the fifth day post-STZ 
injection and was considered the first day of treat-
ment. For a period of 21 days, the treatment persisted. 
Animal grouping 
Group A: Control rats received 1 ml of distilled 
water once daily. 
Group B: Diabetic control rats received 1 ml of 
distilled water once daily. 
Groups C: STZ-induced diabetic rats admini-
stered 100 mg/kg body weight ethanolic extract of M. 
oleifera flower once daily. 
Group D: STZ-induced diabetic rats treated 
with 200 mg/kg body weight ethanolic extract of M. 
oleifera flower once daily. 
Group E: STZ-induced diabetic rats treated 
with 300 mg/kg body weight ethanolic extract of M. 
oleifera flower once daily. 
Group F: STZ-induced diabetic rats treated 
with standard antidiabetic drug (glibenclamide 5 
mg/kg body weight) once daily. 
Collection of blood samples and serum prepa-
ration 
After the 21-day treatment, the animals were 
anaesthetized with ethyl ether and sacrificed by 
simple incision of the jugular vein, the blood samples 
were collected into clean, dry, sample bottles for 
serum analyses. Blood samples were left undisturbed 
to clot at room temperature for 30 minutes and then 
centrifuged at 1000 rpm for a period of 15 minutes 
using Uniscope Laboratory centrifuge (Model 
SM800B, Surgifriend Medicals, Essex, England). After 
centrifugation, the supernatants (sera) were aspirated 
using a Pasteur’s pipette. The sera, thus obtained, 
were appropriately labelled and stored in a freezer at -
5oC until required for further analysis. 
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Preparation of tissue homogenate 
Tissues (liver, kidney, and pancreas) were iso-
lated from the dissected rats. The isolated tissues were 
cleansed with blotting paper to remove blood stains, 
weighed and stored immediately in ice cold 0.25M 
sucrose solution. Specific weight of the liver, pair of 
kidney, and pancreas were then subjected to homoge-
nization using mortar and pestle in ice-cold 0.25M 
sucrose solution (1:5w/v). At a speed of 4000 rpm, the 
homogenates were centrifuged for 10 minutes and the 
supernatants were siphoned into appropriately label-
led sample bottles and stored in the freezer (-20oC) 
until needed for further analysis. 
Assay of biochemical parameters 
Serum total cholesterol (TC), triglycerides (TG), 
low density lipoprotein (LDL-C), high density 
lipoprotein (HDL-C), alanine transaminase (ALT) and 
aspartate aminotransferase (AST) were determined 
using the standard kit of Randox laboratories, Co-
Atrim, UK. Malondialdehyde, catalase and super-
oxide dismutase were estimated using the methods 
described by Jiang et al. (29), Aebi (30) and Misra and 
Fridovich (31), respectively. Alkaline phosphatase 
activity was estimated using the method described by 
Wright et al. (32). All spectrophotometric measure-
ments were carried out in a Camspec UV-Visible 
spectrophotometer. The determinations were repli-
cated 5 times (n = 5). 
STATISTICAL ANALYSIS 
Results were presented as mean of replica-
tes±SD. Means were analyzed using a one-way 
analysis of variance (ANOVA), followed by the 
Duncan Multiple Range Test to determine significant 
differences in all the parameters. Differences with 
values of p < 0.05 were considered statistically signi-
ficant (33). 
RESULTS 
Phytochemical screening 
Table 1 shows the result of preliminary phyto-
chemical screening of M. oleifera flowers extract. 
Flavanoids, alkaloids, tannins, phenolics, terpenoids, 
cardiac glycoside, cardenolides and dienolides were 
present. 
Table 1: Phytochemical constituents of Moringa 
oleifera flower 
Phytochemical Inference(+/-) 
Anthraquinones - 
Tannins + 
Phenolics + 
Saponins - 
Terpenoids + 
Alkaloids + 
Steroids - 
Cardiac glycoside + 
Flavonoids + 
Triterpenes - 
Cadenolides and 
Dienolides 
+ 
Key: + Presence of constituents,  - Absence of constituents 
Blood glucose 
Table 2 shows the effect of ethanolic extract of 
M. oleiferaon fasting blood glucose levels of rats 
induced with diabetes via STZ injection. Blood glu-
cose level was significantly elevated (p<0.05) after 
induction of diabetes in STZ-induced diabetic rats 
relative to the control group. However, a significant 
decrease (p < 0.05) was noted at 100, 200, 300 mg/kg of 
ethanolic extract of M. oleifera flower which produced 
more than 70% reduction in glucose level within 2 
weeks of administration. 
Body weight 
Presented in Table 3 is the effect of M. oleiferae 
thanolic extract on weight gain of rats induced with 
diabetes via STZ injection. A significant reduction (p < 
0.05) in body weight was noticed in the diabetic rats. 
STZ diabetic rats lost 35.6 g of body weight by the 21st 
day post-induction of diabetes, while non-diabetic 
animals gained 79.20 g during this period. Gliben-
clamide-treated diabetic rats also gained weight, but 
this weight gain (66 g) was less than that of the control 
animals. Diabetic rats administered ethanolic extract 
of M. oleifera flower and glibenclamide showed sig-
nificantly increased (p < 0.05) body weight gain to 
near-control level. 
Serum lipid profile 
Table 4 shows the effects of administration of 
ethanolic extract of M. oleifera on serum lipid profileof  
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Table 2: Effects of ethanolic extract of M. oleiferaon fasting blood glucose level of STZ- induced diabetic rats 
Group 
Blood glucose (mg/dL) 
After 
Induction 
Week 1 Week 2 Week 3 
A 76.20 ± 6.87a 77.67 ± 5.86a 73.00 ± 3.72a 83.80 ± 3.83a 
B 269.67 ±18.04b 290.20 ± 25.40c 297.67 ±63.01b 326.40 ± 28.9b 
C 331.00 ± 18.00b 179.00 ±11.52b 83.33 ± 5.08a 85.00 ± 8.10a 
D 287.20 ± 19.19b 170.67 ± 0.58b 78.00 ± 4.00a 71.00 ± 6.20a 
E 336.40 ± 15.90b 162.00 ± 12.00b 82.33 ± 2.83a 70.80 ± 7.16a 
F 266.20 ± 21.00b 158.00 ± 10.51b 78.33 ± 1.45a 77.60± 7.60a 
Values are means (n=5) ± SD. (Values with different superscript are significantly different at p<0.05). 
Group A: Control; Group B: Diabetic Control; Group C: Diabetic + (100 mg/kg body weight); Group D: Diabetic + 
(200 mg/kg body weight); Group E: Diabetic + (300 mg/kg body weight); Group F: Diabetic + (5 mg/kg body weight of 
glibenclamide). 
STZ-induced diabetic rats. The values of TG, HDL-C, 
LDL-C, TC and atherogenic index of STZ-induced 
diabetic rat significantly increased (p < 0.05) while 
groups treated with ethanolic extract of M. oleifera 
flower restored their values to near-control levels. 
Serum lipid profile of STZ-induced diabetic rats 
treated with ethanolic extract of M. oleifera flower was 
not significantly different (p > 0.05) from the control 
except group E which had a significantly elevated (p < 
0.05) serum lipid profile when compared with control. 
Antioxidant parameters 
Table 5 presents the effect of oral admini-
stration of ethanolic extract of M. oleifera flower on 
liver, kidney and pancreas malondi-aldehyde con-
centration in the rats induced with diabetes via STZ 
injection. There was a significant decrease (p < 0.05) in 
liver, kidney and pancreas malondialdehydeconcen-
tration of all STZ-induced diabetic rats treated with 
ethanolic extract of M. oleifera flower.  
Table 6 shows the effects of oral administration 
of ethanolic extract of M. oleifera flower on liver, 
kidney and pancreas SOD activity of rats induced 
with diabetes using STZ. A significant decrease (p 
<0.05) in the liver, pancreas and kidney SOD activities 
of all STZ-induced diabetic groups relative to the 
control was observed. However, there was a signi-
ficant elevation (p < 0.05) in the liver, kidney and 
pancreas SOD activity of STZ-induced diabetic rats 
treated with ethanolic extract of M. oleifera flower. 
Table 3: Effects of ethanolic extract of M. oleiferaon the 
body weight ofSTZ-induced diabetic rats 
Group Changes in body weight (g) 
A 79.20 ± 3.83a 
B 35.6 ± 4.62b 
C 56.4 ± 3.08a 
D 60.4 ± 2.06a 
E 53.8 ± 3.27a 
F 66.0 ± 3.8a 
Values are means (n=5) ± SD.  (Values with different 
superscript are significantly different at p<0.05). 
Group A: Control; Group B: Diabetic Control; Group C: 
Diabetic + (100 mg/kg body weight); Group D: Diabetic + 
(200 mg/kg body weight); Group E: Diabetic + (300 mg/kg 
body weight); Group F: Diabetic + (5 mg/kg body weight 
of glibenclamide). 
Table 7 presents the effects of the oral admini-
stration of ethanolic extract of M. oleifera flower on 
liver, kidney and pancreas catalase (CAT) activity of 
STZ-induced diabetic rats. There was a significant de-
crease (p < 0.05) in catalase activity in the liver, kidney 
and pancreas of all STZ-induced diabetic groups with 
respect to the control, while there was a significant 
increase (p < 0.05) in catalase activity of the liver, 
pancreas and the kidney in all STZ-induced diabetic 
rats administered ethanolic extract of M. oleifera flo-
wer. 
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Table 4: Effects of ethanolic extract of M. oleiferaon serum lipid profile of STZ-induced diabetic rats 
Group TC (mg/dL) 
HDL-C 
(mg/dL) 
LDL-C 
(mg/dL) 
TG (mg/dL) 
Atherogenic 
Index (LDL/HDL) 
A 145.6 ± 3.4a 45.8 ± 1.8a 74.8 ± 4.9a 124.94 ± 4.9a 1.64± 0.15a 
B 287.8 ± 20.6b 54.6 ± 5.0c 192.7 ± 12.4b 202.9 ± 18.1b 3.53 ± 0.20b 
C 161.4 ± 15.3a 46.5 ± 2.8ab 79.5 ± 5.4a 142.8 ± 6.0a 1.86 ± 0.14a 
D 152.8 ± 5a 46.5 ± 0.5ab 79.5 ± 3.0a 133.8 ± 13.1a 1.71 ± 0.09a 
E 153.1 ± 7.7a 49.7 ± 2.9b 76.3 ± 6.6a 134.5 ± 10.1a 1.54 ± 0.10a 
F 154.3 ± 12.0a 45.3 ± 0.5a 84.2 ± 6.6a 123.8 ± 11.8a 1.86 ± 0.15a 
Values are means (n=5) ± SD. (Values with different superscript are significantly different at p<0.05). 
Group A: Control; Group B: Diabetic Control; Group C: Diabetic + (100 mg/kg body weight); Group D: Diabetic + (200 
mg/kg body weight); Group E: Diabetic + (300 mg/kg body weight); Group F: Diabetic + (5 mg/kg body weight of 
glibenclamide). 
Table 5: Effect of ethanolic extract of M. oleifera flower on malondialdehyde concentration 
in the liver, kidney and pancreas of STZ-induced diabetic rats 
MDA (nmol/mg x 10-5) 
Group Liver Kidney Pancreas 
A 0.89 ± 0.30a 0.53 ± 0.05a 0.65 ± 0.02a 
B 6.32 ± 0.51b 1.18 ± 0.04c 1.50 ± 0.14c 
C 2.71 ± 0.21a 0.39 ± 0.03ab 1.07 ± 0.16ac 
D 1.74 ± 0.16a 0.59 ± 0.05a 0.83 ± 0.04a 
E 2.36 ± 0.2a 0.74 ± 0.04a 0.24 ± 0.01b 
F 1.16 ± 0.08a 0.21 ± 0.02b 0.38 ± 0.03b 
Values are means (n=5) ± SD.  (Values with different superscript are significantly different at p<0.05). 
Group A: Control; Group B: Diabetic Control; Group C: Diabetic + (100 mg/kg body weight); Group D: Diabetic + (200 
mg/kg body weight); Group E: Diabetic + (300 mg/kg body weight); Group F: Diabetic + (5 mg/kg body weight of 
glibenclamide). 
Table 6: Effect of administration of ethanolic extract of M. oleifera flower on the activity of superoxide 
dismutase of STZ-induced diabetic rats 
SOD (U/mg protein) 
Group Liver Kidney Pancreas 
A 1.40 ± 0.09a 24.43 ± 2.25a 17.34 ± 0.75a 
B 0.93 ± 0.02c 5.69 ± 0.37d 7.13 ± 0.58c 
C 1.13 ± 0.07b 17.64 ± 1.60b 8.20 ± 0.82bc 
D 1.17 ± 0.05b 18.55 ± 1.56b 12.11 ± 1.02b 
E 1.13 ± 0.04b 18.68 ± 1.61b 10.07 ± 0.63b 
F 1.20 ± 0.05b 11.00 ± 1.05c 13.14 ± 0.84ab 
Values are means (n=5) ± SD.  (Values with different superscript are significantly different at p<0.05). 
Group A: Control; Group B: Diabetic Control; Group C: Diabetic + (100 mg/kg body weight); Group D: Diabetic + (200 
mg/kg body weight); Group E: Diabetic + (300 mg/kg body weight); Group F: Diabetic + (5 mg/kg body weight of 
glibenclamide). 
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Table 7: Effect of administration of ethanolic extract of M. oleifera flower on the activity of catalase in the liver, 
kidney and pancreas of STZ-induced diabetic rats 
Catalase (U/mg) 
Group Liver Pancreas Kidney 
A 7.52 ± 3.70a 8.56 ± 3.44ab 5.15 ± 0.15a 
B 1.65 ± 0.41c 3.13 ± 0.59c 1.92 ± 0.04b 
C 4.69 ± 1.15b 6.49 ± 1.77b 2.89 ± 0.53ab 
D 3.75 ± 1.94b 6.91 ± 2.61b 2.32 ± 0.36ab 
E 4.35 ± 1.63b 5.38 ± 1.62bc 2.97 ± 0.15ab 
F 3.89 ± 0.95b 9.18 ± 1.39a 3.17 ± 0.005ab 
Values are means (n=5) ± SD. (Values with different superscript are significantly different at p<0.05). 
Group A: Control; Group B: Diabetic Control; Group C: Diabetic + (100 mg/kg body weight); Group D: Diabetic + (200 
mg/kg body weight); Group E: Diabetic + (300 mg/kg body weight); Group F: Diabetic + (5 mg/kg body weight of 
glibenclamide). 
Serum enzymes 
Table 8 presents the effects of oral admini-
stration of ethanolic extract of M. oleifera flower on 
alanine aminotransferase (ALT) activity in serum and 
liver of rats induced with diabetes using STZ. Serum 
alanine aminotransferase activity of all STZ-induced 
diabetic groups was not significantly different (p > 
0.05) from that of the control. There was also no 
significant difference (p > 0.05) in the liver alanine 
aminotransferase activity of all STZ-induced diabetic 
groups except group B which had a significant 
increase (p < 0.05) with respect to the control.  
Table 8: Effect of administration of ethanolic extract of 
M. oleifera flower on alanine aminotransferase activity of 
STZ-induced diabetic rats 
ALT (IU/L) 
Group Serum Liver 
A 0.025±0.001ab 0.427±0.03ab 
B 0.027±0.001b 2.64±0.05c 
C 0.023±0.001ab 0.12±0.07a 
D 0.022±0.001a 0.15±0.01a 
E 0.025±0.001ab 0.91±0.03b 
F 0.023±0.002ab 0.13±0.010a 
Values are means (n=5) ± SD.  (Values with different 
superscript are significantly different at p<0.05). 
Group A: Control; Group B: Diabetic Control; Group C: 
Diabetic + (100 mg/kg body weight); Group D: Diabetic + 
(200 mg/kg body weight); Group E: Diabetic + (300 mg/kg 
body weight); Group F: Diabetic + (5 mg/kg body weight 
of glibenclamide). 
Table 9: Effect of administration of ethanolic extract of 
M. oleifera flower on aspartate aminotransfarase activity 
of STZ-induced diabetic rats 
AST (IU/L) 
Group Serum Liver 
A 0.035±0.001ab 0.58±0.02a 
B 0.0375±0.002b 3.54±0.15b 
C 0.0314±0.003ab 0.16±0.11a 
D 0.03±0.001a 0.21±0.01a 
E 0.034±0.002ab 0.13±0.04a 
F 0.032±0.002ab 0.18±0.01a 
Values are means (n=5) ± SD. (Values with different 
superscript are significantly different at p<0.05). 
Group A: Control; Group B: Diabetic Control; Group C: 
Diabetic + (100 mg/kg body weight); Group D: Diabetic + 
(200 mg/kg body weight); Group E: Diabetic + (300 mg/kg 
body weight); Group F: Diabetic + (5 mg/kg body weight 
of glibenclamide). 
The effects of oral administration of ethanolic extract 
of M. oleifera flower on aspartate amino-transferase 
activity in serum and liver of rats induced with 
diabetes via STZ injection are shown in Table 9. 
Serum AST activity of all STZ-induced diabetic 
groups was not significantly different (p > 0.05) from 
that of the control. Liver AST activity of all STZ-in-
duced diabetic groups was not significantly dif-ferent 
(p>0.05) from that of the control except group B which 
had a significant elevation (p<0.05). However, there 
was a significant decrease (p<0.05) in the liver and 
serum aspartate amino-transferase activity of rats 
treated with ethanolic extract of M. oleifera flower. 
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Table 10: Effect of administration of ethanolic 
extract of M. oleifera flower on alkaline phosphatase 
activity of STZ-induced diabetic rats 
ALP 
Group Serum Liver 
A 23.76 ± 2.90ab 143.95 ± 11.11ab 
B 28.47 ± 2.32c 251.03 ± 18.00c 
C 25.52 ± 2.02b 136.25 ± 10.99ab 
D 26.46 ± 1.78ab 179.53 ± 15.41b 
E 21.82 ± 2.06a 97.06 ± 7.37a 
F 18.61 ± 1.85a 136.91 ± 10.10ab 
Values are means (n=5) ± SD. (Values with different 
superscript are significantly different at p<0.05). 
Group A: Control; Group B: Diabetic Control; Group C: 
Diabetic + (100 mg/kg body weight); Group D: Diabetic + 
(200 mg/kg body weight); Group E: Diabetic + (300 mg/kg 
body weight); Group F: Diabetic + (5 mg/kg body weight 
of glibenclamide). 
Table 10 displays the effects of oral admini-
stration of ethanolic extract of M. oleifera flower onal- 
kaline phosphatase activity of STZ-induced diabetic 
rats. There was a significant decrease (p < 0.05) in the 
serum and liver alkaline phosphatase of the STZ-
induced diabetic groups when compared to the 
control. Serum and liver alkaline phosphatase activity 
of the untreated STZ-induced diabetic group was 
significantly increased (p < 0.05), while ALP activity in 
the groups treated with ethanolic extract of M. oleifera 
flower was significantly decreased.  
DISCUSSION 
Phytochemical constituents 
Results of the phytochemical screening shows 
the presence of alkaloids and flavonoids which have 
been implicated as possible bioactive agents leading 
to toxicological and antidiabetic effects (34). Basically, 
flavonoids are best known for their antidiabetic 
properties which agree with the report of Soliman (35) 
that M. oleifera flowers possess antioxidant and anti-
diabetic activity owing to the presence of flavonoids. 
Although the hypoglycemic effect of terpe-noids 
appear to involve stimulation of pancreatic β-cells and 
subsequent secretion of preformed insulin (36), one or 
more other chemical constituent(s) of the flower 
especially is/are also likely to have played a pro-
minent part in the hypoglycemic action of the flower 
extract and may be involved in the alterations of 
biochemical parameters in this present study. 
Blood glucose and antidiabetic studies 
Diabetes mellitus is a chronic disease chara-
cterized by high blood glucose levels as a result of 
absolute or relative deficiency of circulating insulin 
levels. In this study, rats induced with diabetes via 
STZ injection exhibited a significant increase (p < 0.05) 
in blood glucose level which corresponds to the report 
of Ghada (35) and Tendelet al. (37) on streptozotocin- 
induced diabetes. According to Ghada (35) and 
Tendelet al. (37), the elevated glucose level may be 
attributed to destruction of pancreatic β-cells by STZ, 
causing a notable reduction in insulin release by 
pancreatic β-cells. Studies have shown that a variety 
of plant part extracts are able to effectively reduce 
blood glucose level in STZ-induced diabetic rats (38). 
Ethanolic extract of M. oleifera flower demonstrated 
glucose-lowering effect in hyper-glycaemic rat 
possibly through the stimulation of β-cells and/or as a 
result of its insulin-like activity. The possible me-
chanism of hypoglycaemic action of the ethanolic 
extract of M. oleifera flower may be via potentiation of 
insulin secretion from β-cells of the islets of Langer-
hans or as a result of improved blood glucose trans-
port to peripheral tissues (39). 
Antioxidants provide defence against dege-
nerative diseases such as cancer, Alzheimer’s diseases, 
and coronary heart disease (6). Antioxidants expres-
sed their protective actions through the repression of 
ROS formation, inhibition of enzymes and chelation 
of elements required for free-radical production, 
scavenging reactive species, and up regulation of 
antioxidant defenses (10). The antioxidant enzyme 
superoxide dismutase (SOD) has been described as 
the first line of defense enzymes against free radicals 
(35). In this study, the significant elevation in activity 
of liver superoxide dismutase (SOD) with a significant 
elevation in liver, pancreas and kidney malon-
dialdehyde (MDA) concentration of rats induced with 
diabetes via STZ injection can be attributed to large 
free radicals produced by the hyperglycaemic con-
dition. It was observed that treatment with ethanolic 
extract of M. olifera flowers significantly increased 
SOD and significantly decreased MDA levels in STZ-
induced diabetic rats. This shows that the ethanolic 
extract possesses the potential to lower reactive free 
radical levels which may ameliorate oxidative dama- 
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ge and this may be traceable to the rich presence of 
flavonoids which have antioxidant property (35). M. 
oleifera is a rich source of anti-oxidants (25-27) which 
are largely responsible for its antioxi-dant activity (40-
41). 
Serum lipid profile 
Concentrations of total cholesterol, TG, 
HDL/LDL ratio and coronary risk indices (CRI) are 
indicators of susceptibility to cardiovascular diseases 
(CVDs) (42). The marked reduction of these parame-
ters in STZ-induced diabetic rats administered the 
extract compared to those administered glibencla-
mide demonstrates the potential of ethanolic ex-tract 
of M. oleifera flower to reduce the risk of CVDs. 
Treatment of diabetes mellitus with the extract could 
therefore prevent and/or reduce the risk of cardio-
vascular complications of diabetes. Diabetics usually 
have smaller, densely oxidized LDL molecules, which 
may elevate atherogenicity even if the absolute LDL 
cholesterol concentration is not increased (42). This 
study also shows significantly elevated levels of 
triglyceride in diabetic rats in relation to the controls. 
Triglyceride levels were significantly reduced fol-
lowing the treatment with ethanolic extract of M. 
oleifera flower. Thus, by suppressing diabetes-induced 
elevation in lipid levels, ethanolic extract of M. oleifera 
flower may be useful in the reduction of the risk of 
cardiovascular complications of diabetes.  
Enzymes studied 
Elevated levels of aminotransferases in the se-
rum are a common sign of liver and kidney damage 
and are observed more often among diabetics than in 
the general population (43). This study shows that the  
levels of liver aminotransferase (ALT and AST) in-
creased significantly in STZ-induced diabetic un-
treated rats as shown in Tables 7 and 8, respectively. 
The increase in aminotransferase levels may be 
attributed to cellular damage in the liver induced by 
diabetes. Cell damage results to increased permea-
bility leading to the leakage of cytosolic enzymes into 
the blood (44). However, ethanolic extract of M. 
oleifera flower produced a marked significant de-
crease of the elevated AST and ALT activities. This 
decrease may be attributed to the hepatoprotective 
and antioxidant activity of a number of flavonoids in 
the ethanolic extract of M. oleifera flower. This agrees 
with the report of Ghada (35) where it was reported 
that the effect of STZ-diabetes on ALP activity re-
vealed a significant increase in ALP activity of STZ-
induced untreated rats. A marked decrease of serum 
and liver ALP activity of STZ-induced rats after 
treatment with ethanolic extract of Moringa-oleifera 
indicates its protective effect over liver and impro-
vement in liver function efficiency.  
CONCLUSION 
The present study showed that ethanolic 
extract of M. oleifera flower possesses hypo- and 
normoglycemic properties in rats induced with 
diabetes via STZ injection. This indicates that the 
ethanolic extract of M. oleifera contains biologically 
active components. Different doses of the plant extract 
used in this study demonstrated hypolipidemic and 
antioxidant abilities of the flower. This suggests its 
efficacy in the maintenance of glucose homeostasis 
and may be used as a therapeutic alternative in the 
management of diabetes mellitus. It also has beneficial 
effect on various metabolic and enzymatic functions 
of the liver in STZ-induced diabetic rats.  
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SAŽETAK 
Cilj ove studije bio je utvrđivanje antidijabetičnih i antioksidativnih efekata oralno datog etanolskog 
ekstrakta cvetova Moringa oleifera kod miševa sa dijabetesom izazvanim streptozotocinom u dozi od 100, 
200, i 300 mg/kg telesne mase.  
Trideset (30) eksperimentalnih belih miševa muškog pola nasumično je podeljeno u šest grupa: A, B i 
F su označavale kontrolnu, dijabetičnu kontrolnu i referentnu grupu koja je primala lek, dok su grupe 
označene od C do E primile dozu ekstrakta od 100, 200 i 300 mg/kg telesne mase. Uzorci krvi i organa su 
sakupljani zbog analiza nivoa glukoze i antioksidativnih enzima. 
Nivoi glukoze u krvi, serumskih lipida i lipidne peroksidacije, kao i aspartata aminotransferaze (AST), 
alkalne fosfataze (ALP) i alanin aminotransferaze (ALT) bili su značajno smanjeni (p < 0,05) kod miševa sa 
dijabetesom izazvanim streptozotocinom kojima je oralno dat etanolski ekstrakt cveta M. oleifera. Međutim, 
telesna masa i aktivnost katalaze  i superoksid dismutaze bili su značajno povećani (p < 0,05) kada se 
uporede sa kontrolnim grupama.  
Etanolski ekstrakt cveta M. oleifera dat oralno poboljšao je metabolizam masti, uticao na smanjenje 
nivoa glukoze i pokazao blagotvorna svojstva u preveniranju komplikacija  dijabetesa, što je rezultat lipidne 
peroksidacije i oksidativnih sistema kod miševa sa dijabetesom izazvanim streptozotocinom.  It tog razloga 
se može koristiti u terapeutske svrhe za lečenje dijabetesa melitusa. 
Ključne reči: etanolski ekstrakt, antidijabetični, antioksidativni enzimi, Moringa oleifera, 
streptozotocin 
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